Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Febrile Neutropenia 3 Prostatic Neoplasms 2 Neutropenia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Infections 1 Hematologic Neoplasms 1 Early Stage Breast Cancer 1 Cysts 1 Cystectomy 1 Breast Neoplasms 1

Interventions

Letrozole 20 Docetaxel 16 Cyclophosphamide 13 Zoledronic Acid 12 exemestane 11 Trastuzumab 11 Anastrozole 11 Paclitaxel 10 Tamoxifen 9 Capecitabine 9 Fulvestrant 8 Epirubicin 8 pegfilgrastim 7 pertuzumab 6 liposomal doxorubicin 6 abemaciclib 6 Saline Solution 6 palbociclib 5 Sodium Chloride 5 Dexmedetomidine 5 Carboplatin 5 Bupivacaine 5 Bevacizumab 5 ribociclib 4 pegylated granulocyte colony-stimulating factor 4 eribulin 4 Tranexamic Acid 4 Standard of Care 4 Pamidronate 4 Filgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Ciprofloxacin × Clear all

NCT02173262 2017-11-06

OTT14-03

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡